Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keeping up the FDA funding pace

Executive Summary

The House approves a continuing resolution Sept. 24 that funds most of the federal government, including FDA, at fiscal 2008 appropriation levels through March 6, 2009. The money available to FDA will be calculated on the basis of both the level in its appropriations bill and the $150 million added in a supplemental funding package. "Congress is following through with its commitment to provide additional resources for the FDA," notes Rep. Rosa DeLauro, D-Conn., Chair of the House Appropriations panel that oversees the FDA budget. At press time, the Senate was scheduled to vote on the measure on Sept. 27. Without the continuing resolution, funding for the government would cease with the start of fiscal 2009 on Oct. 1. As March approaches, it is likely Congress will pass another continuing resolution to fund the government through the end of fiscal 2009, an appropriations staffer notes. By that time, congressional appropriators will be directing their attention to the FY 2010 spending bills
Advertisement

Related Content

House Omnibus Approps Bill Would Increase FDA Spending By 19% In Fiscal 2009
Advertisement
UsernamePublicRestriction

Register

PS050147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel